PPD ACTTM ResearchKit iPhone App Launches in Canada to Study Postpartum Depression

Toronto’s Women’s College Hospital has brought the PPD ACTTM ResearchKit iPhone app to Canada, after the app launched in the U.S. and Australia last year.

The iPhone app PPD ACTTM is part of a study to expand research into why some women experience postpartum depression (PPD) and postpartum psychosis (PPP).

The PPD ACTTM iPhone app was developed with Apple’s ResearchKit, turning the study mobile-based to allow researchers to further understand more about how to improve detection, prevention and treatments for PPD and PPP.

Dr. Simone Vigod, principal investigator and psychiatrist, WCH, told iPhone in Canada in a statement, “Working alongside colleagues from the U.S., Australia and Europe, we will be using the PPD ACTTM app to gather information to help understand the genetic link of postpartum depression and postpartum psychosis,” further adding “Our goal is to use this data to develop preventative strategies and targeted treatments for women who are at risk of developing these mental health challenges.”

The app itself surveys mothers who have experienced symptoms of PPD or PPP, while those with a history are voluntarily asked if they want to give a DNA saliva sample to researchers, to examine genes in those affected by postpartum depression, and to create treatments in the future.

Screen696x696 46 Screen696x696 47

Studies have concluded roughly 10-15% of Canadian women have suffered from postpartum depression, but researchers have been unable to determine why it only affects some women and not others.

Nearly 14,000 women have already enrolled in the ResearchKit study in the U.S. and Australia. The goal of the study is to gain 100,000 samples collected worldwide, through further expansion of the PPD ACTTM app, which is designed to quickly collect genetic samples and determine and examine trends.

The PPD ACT iOS app is developed by the University of North Carolina at Chapel Hill, and was recently updated to support the Canadian version of the study. Expansion is slated to soon hit the UK and Denmark.